Delivery Order SPE2DB20D1100-SPE2DB25FD8G8
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,249.41 delivery order on August 7, 2025, for Freestyle Libre 3 sensors. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The sensors will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,978.19 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on July 21, 2025, with completion targeted for July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. The sensors will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,114.24 for Freestyle Libre 3 sensors on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $10,655.70 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency awarded a delivery order valued at $3,461.82 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be...
- The Defense Logistics Agency awarded a $1,119.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitive award, with no set-aside designation, is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader federal contract portfolio with the DLA....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,002.08 in Freestyle Libre 3 sensors, with a completion date of September 19, 2025. This competitively awarded contract, issued on September 18, 2025, carries no set-aside designation and operates under firm fixed-price terms. The delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,749.81 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of July 31, 2025. This non-set-aside contract employs firm fixed price terms and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,002.08 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Sensors on September 15, 2025, with completion targeted for September 16, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a delivery order valued at $2,588.88 to AmerisourceBergen Drug Corp for FreeStyle Libre 3 Plus Sensors on June 3, 2025, with completion scheduled for June 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under a larger contract vehicle. The sensors will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD8G8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,299.44 to AmerisourceBergen Drug Corp for Freestyle Libre 3 sensors on August 4, 2025, with completion scheduled for August 5, 2025. This non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger contract vehicle with DLA. The sensors will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a prime vendor for DLA's medical supply chain, AmerisourceBergen provides a comprehensive range of pharmaceutical products and medical devices to support military and veteran healthcare systems globally. The Freestyle Libre 3 sensors represent continuous glucose monitoring devices that support diabetes care within the Defense Health Agency and broader federal healthcare programs, demonstrating the company's role in delivering specialized medical supplies across multiple therapeutic domains to military health services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/4/25 |